Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy

Inclusion Criteria

• •• Ability to understand read and sign the informed consent form.
• •* Age between 30 and \<91 years
• •* Ability to understand and follow instructions and study procedures
• •* Willingness to comply with all study procedures and be available for the duration of the study
• •* Ability to apply eye drop medication and willing to adhere to study medication regimen
• •* Diagnosed with Fuchs dystrophy (clinically and on confocal microscopy) by the study investigator.
• •* Pseudophakic FED with posterior capsule supported, suture-fixated, or sulcus-supported posterior chamber intraocular lens.
• •* Fuchs dystrophy grades 2-4 on the Krachmer grading scale
• •* Presence of central guttae deemed by the investigator to be the chief cause of visual symptoms, rather than cataract or corneal stromal edema
• •* Clear peripheral cornea with an endothelial cell count \>1000 cells/mm2 on specular microscopy
• •* Best corrected visual acuity in the study eye is 20/40 or worse at study enrollment
• •* The patient is dissatisfied with current vision
• •* The patient is otherwise to be offered a corneal graft
• •* For females with reproductive potential, willingness to use highly effective contraception (e.g., hormonal contraception, barrier contraception, intrauterine device, or abstinence).
• •* Indication for surgery may include cataract extraction and posterior chamber intraocular lens implantation